share_log

和元生物(688238.SH)发布2023年度业绩,净亏损1.28亿元,同比由盈转亏

Heyuan Biotech (688238.SH) announced its 2023 annual results, with a net loss of 128 million yuan, changing from profit to loss over the previous year

Zhitong Finance ·  Apr 24 09:50

Heyuan Biotech (688238.SH) disclosed its 2023 annual report, and the company achieved revenue of 2 in 2023...

Zhitong Finance App News, Heyuan Biotech (688238.SH) disclosed the 2023 annual report. The company achieved revenue of 205 million yuan in 2023, a year-on-year decrease of 29.69%; net profit loss to mother of 128 million yuan, which changed from profit to loss over the previous year; after deducting loss of 134 million yuan in non-net profit, which changed from profit to loss over the previous year; basic earnings per share -0.199 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment